Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF)

NCT00141778 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

455

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Placebo
DRUG: Ramipril
DRUG: Spironolactone

Sponsor

Vanderbilt University

Collaborators

[object Object]